FilingSEC EDGAR8-K
Lantern Pharma Receives Nasdaq Deficiency Notice Regarding Market Value
· SEC accepted
StageCompliance Grace Period
Filing content
Lantern Pharma received a notice from Nasdaq for failing to meet the minimum market value of listed securities requirement for 30 consecutive business days and has until March 24, 2027, to regain compliance.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…